TAK-003: development of a tetravalent dengue vaccine

Introduction Dengue incidence has increased over the past few decades. One tetravalent dengue vaccine based on a yellow fever backbone has been approved, but due to increased risk of severe disease in dengue-naïve recipients, its use is limited to individuals with prior dengue exposure.Areas covered...

Full description

Bibliographic Details
Published in:	Expert Review of Vaccines
Main Authors:	Xavier Sáez-Llorens, Rodrigo DeAntonio, Jenny Guek Hong Low, Pope Kosalaraksa, Hansi Dean, Mayuri Sharma, Vianney Tricou, Shibadas Biswal
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Subjects:	Dengue efficacy immunogenicity safety TAK-003 vaccine
Online Access:	https://www.tandfonline.com/doi/10.1080/14760584.2025.2490295

Similar Items

Immunogenicity, Safety and Efficacy of the Dengue Vaccine TAK-003: A Meta-Analysis
by: Maria Elena Flacco, et al.
Published: (2024-07-01)

Pregnancy outcomes following unintentional exposure to TAK-003, a live-attenuated tetravalent dengue vaccine
by: Martina Rauscher, et al.
Published: (2025-12-01)

Severe dengue hemorrhagic fever after TAK-003 dengue vaccination: A case report of a potential vaccine-associated adverse reaction
by: Pinyo Rattanaumpawan, et al.
Published: (2025-11-01)

A Methodological Approach to Measuring the Impact of TAK-003 for the Prevention of Dengue in Dourados, Brazil: Optimizing Strategies for Public Health
by: Benedetta Ghezzi, et al.
Published: (2025-01-01)

The evolution of dengue fever trends in the Central-West Region of Brazil: An 11-year analysis of incidence data from 2013 to 2023 in Mato Grosso do Sul
by: Cristina Valencia, et al.
Published: (2025-12-01)

State of the Art on Vaccine Development Against Dengue Infection: Scoping Review of the Literature
by: Davide Marangoni, et al.
Published: (2025-09-01)

Dengue Vaccine Development and Deployment into Routine Immunization
by: Annelies Wilder-Smith, et al.
Published: (2025-04-01)

Unveiling the complexity of vaccine hesitancy: A narrative review focusing on dengue vaccination
by: Rachata Charoenwisedsil, et al.
Published: (2025-12-01)

Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults
by: Inge LeFevre, et al.
Published: (2023-05-01)

Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City
by: Shibadas Biswal, et al.
Published: (2021-06-01)

An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life
by: Sanjay S. Patel, et al.
Published: (2023-08-01)

BRIDGING THE IMMUNOGENICITY OF A TETRAVALENT DENGUE VACCINE CANDIDATE (TAK-003) FROM CHILDREN AND ADOLESCENTS TO ADULTS
by: C. Halim, et al.
Published: (2023-05-01)

The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
by: Raksheeth Agarwal, et al.
Published: (2017-05-01)

The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
by: Raksheeth Agarwal, et al.
Published: (2017-05-01)

Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination
by: Claire Vigne, et al.
Published: (2017-09-01)

NILAI TOTAL TAK TERATUR TOTAL DARI GABUNGAN TERPISAH GRAF RODA DAN GRAF BUKU SEGITIGA
by: R. D. S. Rahangmetan, et al.
Published: (2015-12-01)

Pesticide Container Rinsing
by: Thomas W. Dean, et al.
Published: (2005-06-01)

Long term T cell response and safety of a tetravalent dengue vaccine in healthy children
by: Sanja Mandaric, et al.
Published: (2024-10-01)

Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
by: Abdulrahman Mohammed Al-Amri, et al.
Published: (2017-01-01)

Effect of Temperature on the Chip Soldering Process with AuGa0.03 Alloy Solder
by: Zhihuan Zhao, et al.
Published: (2020-01-01)

Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
by: Vianney Tricou, et al.
Published: (2023-03-01)

Design and Synthesis of Fluorescence-Labeled TAK779 Analogs as Chemical Probes
by: Hiroyuki Konno, et al.
Published: (2025-06-01)

Paclitaxel induces apoptosis through the TAK1–JNK activation pathway
by: Di Yu‐Wei, et al.
Published: (2020-08-01)

Abelia x grandiflora 'Sherwoodii'
by: Edward F. Gilman
Published: (2004-10-01)

Stress From Caregiving
by: Donna Davis, et al.
Published: (2006-08-01)

Show Me My DNA: Engaging Florida Elementary Students in Biotechnology
by: Patricia Fajardo-Cavazos, et al.
Published: (2006-11-01)

The Herd Health Handbook for Goat Producers: Control of Parasites in Goats
by: Ray Mobley, et al.
Published: (2009-12-01)

Sunn Hemp - A Cover Crop in Florida
by: Yuncong Li, et al.
Published: (2009-09-01)

Sunn Hemp—A Promising Cover Crop in Florida
by: Qingren Wang, et al.
Published: (2015-09-01)

Stinging Nettles of Florida: Cnidoscolus
by: Wendy B. Zomlefer
Published: (2009-01-01)

The Efficacy of the Combination of Naproxen and Fexofenadine (SJP-003) to Prevent or Reduce Side Effects of Receiving Multiple Travel Vaccines: A Case Report
by: Pantea Kiani, et al.
Published: (2022-07-01)

Analisis Sistem Pengendalian Piutang Terhadap Piutang Tak Tertagih Pada Koperasi Swamitra Wahana Putra Bengkalis
by: M. Khairul Amri, et al.
Published: (2017-06-01)

ANALISIS KINERJA SIMPANG TAK BERSINYAL KAWASAN PEREKONOMIAN PASAR BEKA SIMONGAN SEMARANG
by: Wardana Galih Pamungkas, et al.
Published: (2023-03-01)

Dual regulation of phaseol on osteoclast formation and osteoblast differentiation by targeting TAK1 kinase for osteoporosis treatment
by: Lihua Tan, et al.
Published: (2025-10-01)

Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in Thailand.
by: Jing Shen, et al.
Published: (2025-06-01)

Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in Thailand
by: Jing Shen, et al.
Published: (2025-06-01)

Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
by: Ngoc Huu Tran, et al.
Published: (2019-10-01)

Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial
by: Mark Turner, et al.
Published: (2020-10-01)

TAK-861, a potent, orally available orexin receptor 2-selective agonist, produces wakefulness in monkeys and improves narcolepsy-like phenotypes in mouse models
by: Kayo Mitsukawa, et al.
Published: (2024-09-01)

Regulation of TAK–TAB Complex Activation through Ubiquitylation
by: Jie Zhang, et al.
Published: (2024-04-01)